Member Info for Riesgo

German uncertainty supports the view that Avacta just stepped ahead of the game. While deciding if other tests are good enough, Avacta could soon steal the show.

Possibly to provide best chance to work with the frozen stuff. Eskimo lives matter.

What I would really love is AS explaining to our national media that even if the U.K. approved AffiDX we no longer have capacity to supply the U.K. owing to FDA approval and world wide sales agreements. A picture of him gesturing with a finger raised towards a Bell end would be perfect.

Good news from across the pond perhaps.

Selling snow to Eskimos and LFTs to the U.K. demonstrates there will always be stupid customers.

Another Boris answer suggests the U.K. manufacturer has the largest capacity in Europe, which indicates limited competition for Avacta in the EU.

According to Boris when answering Ellie Reeves point on U.K. manufacturers awaiting U.K. approval, despite being approved by the EU.

You could also make a business enquiry to Medusa19. As far as I know BioServ had sold out but expecting new stock soon. But for both suppliers current regulations prevent sales until the overdue desk top validation review is completed.

Boris wafted good questions away by saying the opposition doesn’t know what they are talking about. He says the largest LFT manufacturer’s factory is in Nottingham.
Amazing.

I’ve just asked when they expect MeduFlow will be available to buy for home use.
Apparently they are going to get back to me.

Should say MeduFlow web page

Using the new ? link on their Medusa web page.

But can LFTs currently in use still be frigged to give a positive result? Which is good for people who want time off work, especially in the absence of secondary proof, such as a PCR test or an LFT that cannot be frigged. Can AffiDX be frigged to give positive?

Infinis, it appears the looking glass was used before February 21 to pivot away from the U.K. to Europe. From the RNS;

‘On the basis of these excellent initial data, the Company will now progress to a full clinical validation with a larger number of patient samples to CE mark the test for professional use, aiming to bring the test to market in Europe around the end of the first quarter of this year.‘

If not already mentioned the Spanish version is not as advanced as the English version. It doesn’t give a telephone number for business enquiries.

The shorters bailing out this week will cause a blue week in my view. Suddenly there is huge interest in Scientific incompetence blocking the desktop review and was probably unexpected by the shorters. The pressure to complete the desktop review this week will immense in order to try and swerve investigations into why frozen samples are used. This was not the situation last week and will unnerve the shorters. You may or may not agree with this logic.

Agree, short its best. 'Is our Government aware that a British LFT manufacturer has been forced to ask Spanish Authorities to validate their test and they are not allowed to sell their world beating LFT in the UK?

Using frozen samples sounds like a good idea for when you can't be arsed to get fresh samples, or the shops are closed.

Peto sounds like a clown who is probably best placed in a University where he cannot normally do any harm. Has he never heard of right first time? What sort of validation tester publicly says under emergency conditions ‘Normally it takes five years for a company to make a kit that it puts to market and lots of work and version 2, 3, 4, 5 before it’s stable enough to use’. Why would Avacta even waste their time submitting a test they know is not good enough. Peto should publicly acknowledge that Avacta have submitted an excellent test that others have validated but the U.K. can’t be arsed to validate. because it has Chinese ones.

The Medusa19 AffiDX pages in English are ahead of the Spanish equivalent, which still say ‘coming soon’. No number is given for business enquiries like there is for the English version.